Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.095
-0.055 (-4.78%)
May 20, 2026, 1:25 PM EDT - Market open

Cocrystal Pharma Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Cocrystal Pharma stock has a consensus rating of "Strong Buy" and an average price target of $8.00. The average 1-year stock price forecast is 630.59% higher than the current stock price, while the lowest is $6.00 (+447.95%) and the highest is $10 (+813.24%).

Price Target: $8.00 (+630.59%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$8.00$8.00$10
Change+447.95%+630.59%+630.59%+813.24%
* Price targets were last updated on Jun 20, 2025.

Analyst Ratings

The average analyst rating for Cocrystal Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$6
Strong BuyMaintains$7$6+447.95%Jun 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+539.27%Jan 22, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$7
Strong BuyMaintains$10$7+539.27%Aug 22, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+813.24%May 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+813.24%Apr 4, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.68
from -0.78
EPS Next Year
-0.65
from -0.68
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-1.93-4.77-1.86-1.72-0.78-0.68-0.65
EPS Growth
-------
Forward PE
-------
No. Analysts
-----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202620272028
High--
Avg--
Low--

EPS Forecast

EPS202620272028
High-0.64-0.67
Avg-0.68-0.65
Low-0.72-0.63

EPS Growth

EPS Growth202620272028
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.